Lenovo continues to invest in R&D, with R&D expenses up nearly 14% year-on-year to US$621 million. At the recent global ...

Lenovo Group Limited (HKSE: 992) (ADR: LNVGY), together with its subsidiaries (‘the Group’), today announced Q3 results for fiscal year 2024/25, reporting significant increases in overall group ...

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News: ...

About the Cystic Fibrosis Trust Cystic Fibrosis Trust is the only UK-wide charity dedicated to uniting for a life unlimited for everyone affected by cystic fibrosis. The Trust funds cutting edge ...

In a report released today, Toni Kaplan from Morgan Stanley maintained a Hold rating on BrightView Holdings (BV – Research Report), with a price target of $16.00. The company’s shares closed ...

2-Year U.S. Treasury Note Continuous Contract $102.770 0.020 0.02% 5-Year U.S. Treasury Note Continuous Contract $106.539 0.063 0.06% 10-Year U.S. Treasury Note Continuous Contract $109.266 0.094 ...

The 67th running of the Daytona 500 will kick off the 2025 NASCAR season on Sunday and seven former winners are entered, including 20-1 longshot William Byron, last year's champ. The 27-year-old ...

Denny Hamlin is the only three-time winner in the 2025 Daytona 500 field, making him one of six drivers to ever win at least three Daytona 500s. He will try to become the third driver to win the ...

The 2025 Chevy Blazer EV SS, Chevrolet’s fastest SS vehicle ever made, earned the right to become the first electric Daytona 500 pace car. With up to 615 hp, the electric SUV can hit 0 to 60 mph ...

Should you buy the Bruvi BV-01 Brewer? If you like the convenience of a pod-based coffee machine but still want a quality cup of coffee, the Bruvi Brewer is worth the investment. It’s more ...

BV500 reaches second milestone, with the advancement of multiple broadly profiled and highly potent oral Lead candidates with demonstrated broad-spectrum in vitro and in vivo efficacy against non ...

Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Genomic Data Analysis and Interpretation Market Opportunities and Strategies ...